Stevanato Group Spa EBIT

Stevanato Group Spa (STVN) currently reports a EBIT of $200M as of March 2026. That compares with $200M in the prior-year period — up 1.8% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Stevanato Group Spa's EBIT history and peer comparisons.

Stevanato Group Spa's EBIT increased from $200M to $200M — a 1.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Stevanato Group Spa's EBIT of $200M is lower than the Healthcare sector average of $23B. That is roughly 99.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Stevanato Group Spa reported $200M in EBIT as of March 2026. That compares with $200M in the prior-year period — up 1.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Stevanato Group Spa, and consider following STVN for alerts when major investors trade the stock.